BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) shares hit a new 52-week high on Monday . The stock traded as high as $1.74 and last traded at $1.69, with a volume of 10528 shares trading hands. The stock had previously closed at $1.65.
BioRestorative Therapies Stock Performance
The company’s 50 day moving average price is $1.62 and its 200 day moving average price is $1.56. The company has a market cap of $2.84 billion, a price-to-earnings ratio of -1.62 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Read More
- Five stocks we like better than BioRestorative Therapies
- Financial Services Stocks Investing
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Airline Stocks – Top Airline Stocks to Buy Now
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- The Most Important Warren Buffett Stock for Investors: His Own
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
